FDA Eliminates the need for Paper Device Submissions
Perhaps no aspect of Regulatory Information Management (RIM) is more complicated than CMC changes. A wide variety of stakeholders are involved, from manufacturing/supply change to corporate quality to regulatory affairs and regulatory operations. A diverse set of independent or loosely […]
Recently, the FDA issued a final rule to amend regulations on medical device premarket submissions to remove requirements for paper and multiple copies. Instead, sponsors will submit a single submission in electronic format. Because a medical device premarket submission in electronic […]
Most people think of Regulatory Information Management (RIM) as a set of tools and processes to manage product submissions and registrations, track regulatory commitments, and integrate regulatory correspondence. But for large companies planning product divestitures, RIM provides a vital function. […]
On July 17th, the FDA and Duke Margolis Center for Health Policy sponsored a workshop entitled “Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations”. The sessions featured 24 speakers representing the FDA, EMA, large pharma, CROs/AROs, clinical vendors, […]
[Reading time 5 minutes] Acceptance testing has always been an important part of our lives at Ennov PV. Understandably, our customers have high expectations with respect to quality in the products that we deliver. Pharmacovigilance software is synonymous with reliability […]
Ennov will once again be exhibiting at the SCOPE Summit for Clinical Ops Executives. This year marks the 10th annual SCOPE conference and Ennov’s 2nd year participating. The SCOPE Summit 2019 takes place 18-21 February at the Hyatt Regency Orlando […]
There is a growing emphasis on signal detection and signal management in Pharmacovigilance. Companies must be able to manage signals detected: evaluate them to understand the clinical risk in light of multiple impacting factors, in a demonstrably controlled manner. Benefit/risk […]
Ennov will be exhibiting at the Society of Clinical Data Management (SCDM) Annual Conference, being held in Seattle-Bellevue, Washington (USA), from 23-26 September 2018. The SCDM Annual Conference is the world’s largest Clinical Data Management Conference, offering unrivalled opportunities to […]
The 2018 Ennov User Group Meeting was recently held in New Orleans, Louisiana. Over 100 Ennov users from 10 different countries participated in the three-day meeting along with 15 Ennov employees. There were three different tracks offered this year, which […]
With the release of the new Eudravigilance system on 22nd November 2017, the European Medicines Agency (EMA) have introduced greater access to adverse event data stored in the central repository. Furthermore, on the same day a new update (Revision 1) […]
Managing essential documentation for clinical trials has become quite complex in today’s clinical research environment. Study sponsors are required to implement a quality system to ensure regulatory compliance of data and documentation and ensure availability of study documentation throughout the […]
Our Speakers
Clinical expert
Pharmacovigilance expert
Regulatory expert
Marketing VP
Chet Shemanski is a proven business and information technology professional with extensive experience serving the healthcare and global life sciences industries. He has specific expertise in software product commercialization including product management, product marketing, solution strategy, and alliance management. Chet is a subject matter expert in eClinical and eRegulatory technologies, the author of industry journal articles and a speaker at industry conferences.